Postmarketing Colitis Cases Associated With Alpelisib Use Reported to the US Food and Drug Administration

被引:3
|
作者
Sullivan, Kathleen M. [1 ]
Dores, Graca M. [1 ]
Nayernama, Afrouz [1 ]
Prowell, Tatiana M. [2 ,3 ]
Pradhan, Shan M. [2 ]
Osgood, Christy [2 ]
Jones, S. Christopher [1 ]
机构
[1] US FDA, Div Pharmacovigilance, Off Surveillance & Epidemiol, Ctr Drug Evaluat, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA
[2] US FDA, Off Oncol Dis, Ctr Drug Evaluat, Silver Spring, MD USA
[3] Johns Hopkins Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA
关键词
D O I
10.1001/jamaoncol.2022.3249
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1503 / 1505
页数:4
相关论文
共 50 条
  • [31] Adverse Events Associated With Botox as Reported in a Food and Drug Administration Database
    Ahsanuddin, Salma
    Roy, Savannah
    Nasser, Wissam
    Povolotskiy, Roman
    Paskhover, Boris
    AESTHETIC PLASTIC SURGERY, 2021, 45 (03) : 1201 - 1209
  • [32] Adverse Events Associated With Botox as Reported in a Food and Drug Administration Database
    Salma Ahsanuddin
    Savannah Roy
    Wissam Nasser
    Roman Povolotskiy
    Boris Paskhover
    Aesthetic Plastic Surgery, 2021, 45 : 1201 - 1209
  • [33] DICLOFENAC-ASSOCIATED HEPATOTOXICITY - ANALYSIS OF 180 CASES REPORTED TO THE FOOD-AND-DRUG-ADMINISTRATION AS ADVERSE REACTIONS
    BANKS, AT
    ZIMMERMAN, HJ
    ISHAK, KG
    HARTER, JG
    HEPATOLOGY, 1995, 22 (03) : 820 - 827
  • [34] Improving the Food and Drug Administration's Mandate to Ensure Postmarketing Drug Safety
    Qato, Dima M.
    Alexander, G. Caleb
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (14): : 1595 - 1596
  • [35] Fatal neutropenic enterocolitis associated with docetaxel use: A review of cases reported to the United States Food and Drug Administration Adverse Event Reporting System
    Singh, Pritpal
    Nayernama, Afrouz
    Jones, S. Christopher
    Kordestani, Laleh Amiri
    Fedenko, Katherine
    Prowell, Tatiana
    Bersoff-Matcha, Susan J.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (04) : 923 - 928
  • [36] Cases of Ischemic Optic Neuropathy Associated With Phosphodiesterase-5 Inhibitor Use Reported to the Food and Drug Administration Adverse Event Reporting System
    Pomeranz, Howard D.
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2016, 36 (02) : 221 - 222
  • [37] Postmarketing commitments for novel drugs and biologics approved by the US Food and Drug Administration: a cross-sectional analysis
    Wallach, Joshua D.
    Luxkaranayagam, Anita T.
    Dhruva, Sanket S.
    Miller, Jennifer E.
    Ross, Joseph S.
    BMC MEDICINE, 2019, 17 (1)
  • [38] Postmarketing safety of orphan drugs: a longitudinal analysis of the US Food and Drug Administration database between 1999 and 2018
    Fan, Min
    Chan, Adrienne Y. L.
    Yan, Vincent K. C.
    Tong, Xinning
    Lau, Lauren K. W.
    Wan, Eric Y. F.
    Tam, Eliza Y. T.
    Ip, Patrick
    Lum, Terry Y.
    Wong, Ian C. K.
    Li, X.
    ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
  • [39] Postmarketing safety of orphan drugs: A longitudinal analysis of US Food and Drug Administration database between 2006 and 2015
    Chan, Adrienne Y. L.
    Fan, Min
    Yan, Vincent K. C.
    Tam, Eliza Y. T.
    Chan, Esther W.
    Wong, Ian C. K.
    Li, Xue
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 564 - 564
  • [40] Postmarketing safety of orphan drugs: a longitudinal analysis of the US Food and Drug Administration database between 1999 and 2018
    Min Fan
    Adrienne Y. L. Chan
    Vincent K. C. Yan
    Xinning Tong
    Lauren K. W. Lau
    Eric Y. F. Wan
    Eliza Y. T. Tam
    Patrick Ip
    Terry Y. Lum
    Ian C. K. Wong
    X. Li
    Orphanet Journal of Rare Diseases, 17